This proposal will be the first to experimentally and computationally assess the mechanical impact of closed reduction treatment on infants with developmental dysplasia of the hip (DDH), enabling the development of innovative pediatric rehabilitation interventions to decrease treatment duration and improve outcomes. DDH requires medical treatment in 2/1000 infants. Early diagnosis and treatment with a Pavlik harness, a 70-year-old solution that holds the infant?s hips in a flexed and abducted position for 24 hours/day for up to 20 weeks, are key to correcting DDH. However, the treatment has a 20% failure rate, requiring surgical intervention. Motion, muscle activity, and adequate joint contact are key to neonatal musculoskeletal development, yet no research has sought to understand the role of passive lying, active kicking, and body position on the development of the infant hip. Our central hypothesis is that a quantifiable combination of active muscles and hip position produced by the Pavlik harness induce a specific but currently unknown mechanical loading at the hip joint, during passive lying and active motion, which encourages correct hip development.
Aim 1 will quantify passive and active hip mechanics of infants undergoing DDH treatment. Infants newly diagnosed with DDH will undergo 2 biomechanical test sessions in our laboratory before and after Pavlik harness treatment. We will monitor DDH infants in their daily life using activity sensors to quantify body orientation and time spent passive versus active. Clinical outcomes will be tracked during and after treatment during 6 visits over 2 years.
This Aim will lend insight into patient selection for closed reduction treatment, help define the ideal treatment duration, and lead to directed therapies.
Aim 2 will evaluate mechanical loading of the healthy hip by the Pavlik harness. The magnitude, direction, and frequency of forces at the hip due to active kicking attempts or passive lying while wearing the Pavlik harness are unknown, preventing the development of new therapies for DDH. We will instrument the Pavlik harness with sensors to evaluate the forces applied to the harness during wear to understand how the harness works to mechanically load the healthy infant hip during activity and passive lying.
Aim 3 will develop computational models of the infant hip undergoing closed reduction. Experimental muscle and hip motion of DDH infants and patient-specific geometry from Aim 1 and forces induced on the Pavlik harness during active motion and passive lying from Aim 2 will serve as inputs to musculoskeletal and finite element models. These computational models of the infant hip joint undergoing closed reduction will support the development of improved DDH therapies. The expected outcome of this work is a more complete understanding of how the Pavlik harness works to translate passive and active forces to the infant hip. The results will provide valid experimental data and computational models that can serve as the basis for our future investigations aimed at developing innovative solutions for infants and families impacted by DDH.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
5P20GM125503-03
Application #
10117416
Study Section
Special Emphasis Panel (ZGM1)
Program Officer
Davani, Behrous
Project Start
2019-08-01
Project End
2023-01-31
Budget Start
2020-02-01
Budget End
2021-01-31
Support Year
3
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Arkansas for Medical Sciences
Department
Type
DUNS #
122452563
City
Little Rock
State
AR
Country
United States
Zip Code
72205
Rasche, L; Alapat, D; Kumar, M et al. (2018) Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma. Leukemia :
Jenkins, Samir V; Vang, Kieng B; Gies, Allen et al. (2018) Sample storage conditions induce post-collection biases in microbiome profiles. BMC Microbiol 18:227
O'Brien, Charles A; Morello, Roy (2018) Modeling Rare Bone Diseases in Animals. Curr Osteoporos Rep 16:458-465
Ambrogini, Elena; Que, Xuchu; Wang, Shuling et al. (2018) Oxidation-specific epitopes restrain bone formation. Nat Commun 9:2193
Went, Molly; Sud, Amit; Försti, Asta et al. (2018) Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma. Nat Commun 9:3707
Piccolo, Brian D; Graham, James L; Stanhope, Kimber L et al. (2018) Diabetes-Associated Alterations in the Cecal Microbiome and Metabolome are Independent of Diet or Environment in the UC Davis Type 2-Diabetes Mellitus Rat Model. Am J Physiol Endocrinol Metab :
Rasche, Leo; Angtuaco, Edgardo J; Alpe, Terri L et al. (2018) The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma. Blood 132:59-66
Xiong, Jinhu; Almeida, Maria; O'Brien, Charles A (2018) The YAP/TAZ transcriptional co-activators have opposing effects at different stages of osteoblast differentiation. Bone 112:1-9
Wongsurawat, Thidathip; Athipanyasilp, Niracha; Jenjaroenpun, Piroon et al. (2018) Case of Microcephaly after Congenital Infection with Asian Lineage Zika Virus, Thailand. Emerg Infect Dis 24:
Xiong, Jinhu; Cawley, Keisha; Piemontese, Marilina et al. (2018) Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss. Nat Commun 9:2909

Showing the most recent 10 out of 11 publications